company background image
UBI

Universal Biosensors ASX:UBI Stock Report

Last Price

AU$0.24

Market Cap

AU$50.8m

7D

4.3%

1Y

-72.7%

Updated

09 Dec, 2022

Data

Company Financials
UBI fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

UBI Stock Overview

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia.

Universal Biosensors, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Universal Biosensors
Historical stock prices
Current Share PriceAU$0.24
52 Week HighAU$1.04
52 Week LowAU$0.22
Beta1.01
1 Month Change0%
3 Month Change-18.64%
1 Year Change-72.73%
3 Year Change17.07%
5 Year Change-20.00%
Change since IPO-76.00%

Recent News & Updates

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Oct 10
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Recent updates

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Oct 10
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

Apr 28
Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

May 13
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

Feb 24
Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Jan 20
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

Dec 15
The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

Shareholder Returns

UBIAU Medical EquipmentAU Market
7D4.3%-2.3%-2.5%
1Y-72.7%-10.0%-5.2%

Return vs Industry: UBI underperformed the Australian Medical Equipment industry which returned -10% over the past year.

Return vs Market: UBI underperformed the Australian Market which returned -5.2% over the past year.

Price Volatility

Is UBI's price volatile compared to industry and market?
UBI volatility
UBI Average Weekly Movement11.6%
Medical Equipment Industry Average Movement10.0%
Market Average Movement8.9%
10% most volatile stocks in AU Market15.8%
10% least volatile stocks in AU Market4.1%

Stable Share Price: UBI is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: UBI's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200181John Sharmanhttps://www.universalbiosensors.com

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens’ Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin.

Universal Biosensors, Inc. Fundamentals Summary

How do Universal Biosensors's earnings and revenue compare to its market cap?
UBI fundamental statistics
Market CapAU$50.84m
Earnings (TTM)-AU$18.63m
Revenue (TTM)AU$4.99m

10.2x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UBI income statement (TTM)
RevenueAU$4.99m
Cost of RevenueAU$3.07m
Gross ProfitAU$1.92m
Other ExpensesAU$20.55m
Earnings-AU$18.63m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.088
Gross Margin38.51%
Net Profit Margin-373.23%
Debt/Equity Ratio0.2%

How did UBI perform over the long term?

See historical performance and comparison